Calamp Corp. (CAMP) Live Share Price, Invest From India

Calamp Corp. Stock Performance

as on March 13, 2026 at 6:59 am IST

Day's Low
Day's High
$5.26
Day's Price Range
$6.00
$5.36
1.87%
Downside
11.94%
Upside
52 Week's Low
52 Week's High
$1.31
52-Week Price Range
$7.75
$5.36
75.65%
Downside
44.59%
Upside

Calamp Corp. share price movements today

Previous Close: $5.60
Open: $5.50
Volume: 394.3K
Day's Low - High: $5.26 - $6.00
52 Week Low - High: $1.31 - $7.75

Calamp Corp. Historical Returns

1 Month Return: + 27.56 %
3 Month Return: -13.71 %
1 Year Return: + 6.06 %
3 Year Return: -93.91 %
5 Year Return: -97.97 %

Calamp Corp. Stock Fundamentals & Key Indicators

Check Calamp Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$313.9M

EPS (TTM)

-0.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.27

Industry PE ratio

8.555337837837838

PEG Ratio

EBITDA

-50.4M

Revenue (TTM)

3.5M

Profit Margin

0.00%

Return On Equity TTM

-145.07%

Calamp Corp. Stock Valuation

Track how Calamp Corp. P/E has moved over time to understand its valuation trends.

Calamp Corp. in the last 5 years

Overview
Trends

Lowest (-46.37x)

November 30, 2023

Today (-0.27x)

March 12, 2026

Industry (8.56x)

March 12, 2026

Highest (77.63x)

August 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -0.27x

Calamp Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Calamp Corp. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Calamp Corp.	SELL	$313.9M	-97.97%	-0.27	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.8B	125.34%	138.96	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$126.8B	129.73%	32.58	32.94%
Beone Medicines Ltd	NA	$35.3B	NA	123.64	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$81.6B	64.31%	18.62	31.41%

Stock Returns calculator for Calamp Corp. Stock including INR - Dollar returns

The Calamp Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Calamp Corp. investment value today

Current value as on today

₹1,07,305

Returns

₹7,305

(+7.3%)

Returns from Calamp Corp. Stock

₹1,515 (+1.52%)

Dollar Returns*

₹5,789 (+5.79%)

Analyst Recommendation on Calamp Corp. Stock

Based on 9 analysts

SELL

11.11%

Buy

44.44%

Hold

44.44%

Sell

Based on 9 analysts, 44.44% of analysts recommend a 'SELL' rating for Calamp Corp.. Average target price of $8.75

Calamp Corp. Share Price Target

Get share price movements and forecasts by analysts on Calamp Corp..

What analysts predicted

38.74%UPSIDE

Target Price

$8.75

Current Price

$5.36

Analyzed by

9 Analysts

Target

$8.75

Calamp Corp. target price $8.75, a slight upside of 38.74% compared to current price of $5.36. According to 9 analysts rating.

Calamp Corp. Stock’s Investor Sentiment and Interest

Search interest for Calamp Corp. Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 11, 2026 to March 13, 2026

Change:-17% versus previous 30 day period

Calamp Corp. Quarterly Profit & Loss

All numbers in Millions USD

	Nov 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	53	53	-	-	-	0	0	1	0	0
Gross Profit	-	17	-	-	-	0	0	1	0	0
Operating Income	-	-13	-12	-12	-13	-14	-13	-13	-13	-12
EBITDA	-	-13	-12	-12	-13	-13	-12	-12	-14	-12
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	-
Income Before Tax	-	-12	-12	-12	-13	-13	-12	-12	-15	-40
Income Tax Expense	-	0	-	-	-	0	-	-	-	-
Net Income	-85	-12	-12	-12	-13	-13	-12	-12	-15	-40
Net Profit Margin	-158.52%	-24.22%	0.00%	0.00%	0.00%	-2036.66%	-1449.07%	-840.81%	-1899.25%	-11575.86%

Calamp Corp. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Feb 2021	Dec 2021	Feb 2022	Dec 2022	Feb 2023	Dec 2023	Feb 2024	Dec 2024	Dec 2025
Total Revenue	308	308	295	295	294	294	0	186	0	3
Gross Profit	122	-	121	-	109	-	0	-	0	1
Operating Income	-3	-	-15	-	-45	-	-51	-	-53	-52
EBITDA	18	-	7	-	-44	-	-50	-	-51	-50
Interest Expense	15	-	15	-	6	-	4	-	-	-
Depreciation	-	-	-	-	0	-	1	-	1	-
Income Before Tax	-20	-	-30	-	-44	-	-49	-	-51	-80
Income Tax Expense	0	-	1	-	1	-	0	-	-	-
Net Income	-21	-21	-31	-31	-44	-32	-49	-93	-51	-80
Net Profit Margin	-6.86%	-6.86%	-10.53%	-10.53%	-14.98%	-11.02%	-14083.14%	-50.08%	-7943.40%	-2298.54%

Calamp Corp. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-12	-12	-12	-13	-13	-12	-12	-15	-40
Operating Cash Flow	-11	-11	-13	-9	-11	-14	-10	-11	6
Investing Cash Flow	0	0	0	0	0	0	0	0	-
Financing Cash Flow	0	0	0	0	73	0	0	47	28
Change in Cash	-12	-11	-14	-10	61	-14	-10	36	34

Calamp Corp. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	16	18	-79	-56	-27	-44	-49	-51	-80
Operating Cash Flow	66	47	11	28	-4	-38	-44	-45	-29
Investing Cash Flow	-26	-21	-65	-13	-7	-4	0	0	0
Financing Cash Flow	-2	98	-94	-27	-2	100	0	71	75
Change in Cash	38	123	-149	-12	-15	83	-44	25	46

Global Institutional Holdings in Calamp Corp.

Funds	Holdings
West Paces Advisors Inc	0.01%
Your Advocates Ltd., LLP	0%
Paradigm Capital Management, Inc.	0%
Bridgeway Capital Management, LLC	0%
GSA Capital Partners LLP	0%

See all

Insights on Calamp Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CAMP stock has moved up by 22.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 75.4% return, outperforming this stock by 169.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 26.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -12.43M → -40.28M (in $), with an average decrease of 62.7% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 1.49M → 348.0K (in $), with an average decrease of 51.6% per quarter

About Calamp Corp.

calamp (nasdaq: camp) is leading the internet of things revolution with its extensive portfolio of intelligent communications devices, robust and capable cloud platform, and targeted software applications. calamp enables customers to optimize operations by collecting, monitoring and efficiently reporting business-critical data and desired intelligence from high-value remote assets. with a heritage in the m2m market, calamp has more than five million devices connected to its iot cloud. partners across transportation, oil and gas, and public safety markets leverage calamp to effectively gather mission- and business-critical data to make intelligent, actionable decisions. for more information, please visit www.calamp.com.

Organisation	Calamp Corp.
Headquarters	One Kendall Square, Cambridge, MA, United States, 02139
Industry	Telecommunications Equipment
CEO	Mr. Joshua Mandel-Brehm
E-voting on shares	Click here to vote

Key Management of Calamp Corp.

Name	Title
Mr. Caleb Moore	Chief Business Operations Officer
Dr. Daniel Tardiff Ph.D.	Chief Scientific Officer
Ms. Michelle Gates	Senior VP & Chief People Officer
Mr. Joshua Mandel-Brehm	CEO, President & Director
Dr. Yuri Maricich M.B.A., M.D.	Chief Medical Officer
Dr. Leonard I. Zon M.D.	Founder & Chairman of Scientific Advisory Board
Ms. Alla Sigova Ph.D.	Senior Vice President of Platform
Dr. Satya Kuchimanchi Ph.D.	Senior Vice President of Technical Operations
Dr. Richard A. Young Ph.D.	Founder & Independent Director
Ms. Kelly Gold	Chief Financial Officer

FAQs

What is Calamp Corp. share price today?

Calamp Corp. share price today is $5.36 as on March 13, 2026 at 1:29 am IST at the close of the market. Calamp Corp. share today touched a day high of $6 and a low of $5.26.

What is the 52 week high and 52 week low for Calamp Corp. share?

Calamp Corp. share touched a 52 week high of $7.75 on March 9, 2026 and a 52 week low of $1.31 on June 20, 2025. Calamp Corp. stock price today i.e. March 13, 2026 at 1:29 am IST is closed at $5.36,which is 30.84% down from its 52 week high and 310.73% up from its 52 week low.

What is Calamp Corp.'s market capitalisation today?

Calamp Corp. market capitalisation is $0.00T as on March 13, 2026 at 1:29 am IST.

How to invest in Calamp Corp. Stock (CAMP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Calamp Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Calamp Corp. Shares that will get you 0.2799 shares as per Calamp Corp. share price of $5.36 per share as on March 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Calamp Corp. Stock (CAMP) from India?

Indian investors can start investing in Calamp Corp. (CAMP) shares with as little as ₹92.206 or $1 (as of March 13, 2026 at 3:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹922.06 in Calamp Corp. stock (as per the Rupee-Dollar exchange rate as on March 13, 2026 at 3:41 am IST). Based on Calamp Corp. share’s latest price of $5.36 as on March 13, 2026 at 1:29 am IST, you will get 1.8657 shares of Calamp Corp.. Learn more about fractional shares .

What are the returns that Calamp Corp. has given to Indian investors in the last 5 years?

Calamp Corp. stock has given -97.97% share price returns and 26.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?